Codes / ICD10CM / T37.3X5D

T37.3X5D Adverse effect of other antiprotozoal drugs, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other antiprotozoal drugs, subsequent encounter

Summary

This condition represents a subsequent encounter for an adverse effect resulting from other antiprotozoal medications not classified elsewhere. It applies to patients receiving active treatment for complications or sequelae of such adverse effects, distinct from the initial encounter. The code is used when the focus is on managing ongoing issues related to the adverse reaction.

Causes

Adverse effects may stem from drug toxicity, allergic reactions, or idiosyncratic responses to antiprotozoal agents. These reactions can occur even with standard dosing and may persist beyond the initial treatment phase, requiring ongoing management.

Risk Factors

  • Concurrent use of medications that interact with antiprotozoals.
  • Pre-existing renal or hepatic impairment affecting drug metabolism.
  • History of hypersensitivity to similar drug classes.
  • Lack of proper medication monitoring or dosage adjustments.

Symptoms

  • Gastrointestinal: Nausea, vomiting, or abdominal discomfort.
  • Neurological: Dizziness, confusion, or central nervous system effects.
  • Dermatological: Skin rashes, itching, or hypersensitivity reactions.
  • Systemic: Signs of organ dysfunction or persistent toxicity.

Diagnosis

Clinical evaluation focuses on medication history, symptom persistence, and lab tests (e.g., renal/hepatic function, drug levels). Documentation should confirm the adverse effect and its ongoing impact to justify a subsequent encounter.

Treatment Options

Management may include discontinuing the offending drug, supportive care, or alternative therapies. Treatment is tailored to the specific adverse effect and patient response, with ongoing monitoring for resolution or complications.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Follow-up ensures resolution of symptoms, monitors organ function, and adjusts treatment as needed. Most patients recover with appropriate care, but some may experience lasting effects.

Complications

Potential complications include organ damage (e.g., hepatic or renal), persistent hypersensitivity, or treatment failure due to drug discontinuation. Severe reactions may require intensive care or long-term management.

Lifestyle & Prevention

Patients should adhere to prescribed dosing and report new symptoms promptly. Avoiding known allergens and drug interactions can reduce risk. Healthcare providers should review medication lists regularly to prevent adverse effects.

When to Seek Professional Help

Seek care if symptoms worsen, new symptoms develop, or there are signs of organ dysfunction (e.g., jaundice, reduced urine output). Immediate attention is needed for severe reactions like anaphylaxis or seizures.

Tips for Medical Coders

Use this code for subsequent encounters related to adverse effects of other antiprotozoal drugs. Document the ongoing nature of the condition and any active treatment. Ensure the encounter is not the initial treatment for the adverse effect; use the appropriate initial code for first presentations.

Book a walkthrough

T37.3X5D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.